Carlos Nolasco, MD, FACP, AHSCP-CHS
@carlosnolascomd.com
GIM 🫀 #Hypertension Specialist 🩺 👨⚕️ (AHSCP-CHS) | 🇸🇻 trained | Chicago✶ trained | Lots of 👨💻 | Posts are my own.
This is addressed in the most recent guideline, the 2025 AHA/ACC Multisociety Guideline on Hypertension.
In the guideline, these cases are renamed as “severe hypertension.”
See www.jacc.org/doi/epdf/10...., page 76 (Figure 9).
In the guideline, these cases are renamed as “severe hypertension.”
See www.jacc.org/doi/epdf/10...., page 76 (Figure 9).
September 26, 2025 at 6:43 PM
This is addressed in the most recent guideline, the 2025 AHA/ACC Multisociety Guideline on Hypertension.
In the guideline, these cases are renamed as “severe hypertension.”
See www.jacc.org/doi/epdf/10...., page 76 (Figure 9).
In the guideline, these cases are renamed as “severe hypertension.”
See www.jacc.org/doi/epdf/10...., page 76 (Figure 9).
Referring to ER for severely elevated BP readings without any symptoms.
For example, sending to ER for consistent BP 200/100 mmHg at home without any symptoms.
In almost all cases, these patients should receive titration of their BP-lowering therapy in the outpatient setting.
For example, sending to ER for consistent BP 200/100 mmHg at home without any symptoms.
In almost all cases, these patients should receive titration of their BP-lowering therapy in the outpatient setting.
September 25, 2025 at 7:23 PM
Referring to ER for severely elevated BP readings without any symptoms.
For example, sending to ER for consistent BP 200/100 mmHg at home without any symptoms.
In almost all cases, these patients should receive titration of their BP-lowering therapy in the outpatient setting.
For example, sending to ER for consistent BP 200/100 mmHg at home without any symptoms.
In almost all cases, these patients should receive titration of their BP-lowering therapy in the outpatient setting.